Tian et al. [202] developed PSMA-antibody-conjugated liposomes co-delivering antisense oligonucleotides and oxaliplatin, effectively downregulating PI3K/AKT3 signaling and GLUT-1 expression, inhibiting tumor cell proliferation, migration, and inducing apoptosis. The gene discussed is FOLH1; the disease is neoplasm.